Anton Dallos
Director/Board Member chez SANOCHEMIA PHARMAZEUTIKA AG
Profil
Anton Dallos is currently the Co-Managing Director at Alvetra & Werfft GmbH and Alvetra und Werfft Animal Nutrition GmbH.
He is also a Member-Supervisory Board at SANOCHEMIA Pharmazeutika GmbH and a Member-Extended Presidium at Wirtschaftskammer Burgenland.
In the past, he worked as a Production Assistant at Waldheim Pharmazeutika GmbH.
Postes actifs de Anton Dallos
| Sociétés | Poste | Début |
|---|---|---|
| SANOCHEMIA PHARMAZEUTIKA AG | Director/Board Member | 28/09/1998 |
Alvetra & Werfft GmbH
 Alvetra & Werfft GmbH Pharmaceuticals: MajorHealth Technology Part of SANOCHEMIA Pharmazeutika GmbH, Alvetra & Werfft GmbH is an Austrian company that manufactures and distributes veterinary pharmaceutical products. The private company is based in Vienna, Austria. The CEOs of the company are Werner Josef Frantsits, Anton Dallos. Alvetra & Werfft was acquired by SANOCHEMIA Pharmazeutika GmbH from J. Medinger & Söhne KG on September 21, 2011 for $7.06 million. | Chief Executive Officer | - |
| Alvetra und Werfft Animal Nutrition GmbH | Chief Executive Officer | - |
| Wirtschaftskammer Burgenland | Corporate Officer/Principal | - |
Anciens postes connus de Anton Dallos
| Sociétés | Poste | Fin |
|---|---|---|
Waldheim Pharmazeutika GmbH
 Waldheim Pharmazeutika GmbH Pharmaceuticals: MajorHealth Technology Waldheim Pharmazeutika GmbH manufactures pharmaceutical products. The private company is based in Vienna, Austria. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
SANOCHEMIA Pharmazeutika GmbH
 SANOCHEMIA Pharmazeutika GmbH Pharmaceuticals: MajorHealth Technology SANOCHEMIA Pharmazeutika GMBH engages in the manufacture and distribution of pharmaceutical products. It operates through the following segments: Production, Human Pharmaceuticals, Veterinary Pharmaceuticals, Research and Development, and Others. The Production segment focuses on the synthesis of active pharmaceutical substances, drug formulation and pharmaceutical production. The Human Pharmaceuticals segment comprises of diagnostic activities including products such as X-ray and magnetic resonance imaging agents. The Veterinary Pharmaceuticals segment involves in veterinary medicine production, administration, and drug development. The Research and Development segment implements clinical trials and acquires licenses for the drugs. The company was founded by Werner Josef Frantsits on November 13, 1990 and is headquartered in Vienna, Austria. | Health Technology |
| Wirtschaftskammer Burgenland | |
Alvetra & Werfft GmbH
Alvetra & Werfft GmbH Pharmaceuticals: MajorHealth Technology Part of SANOCHEMIA Pharmazeutika GmbH, Alvetra & Werfft GmbH is an Austrian company that manufactures and distributes veterinary pharmaceutical products. The private company is based in Vienna, Austria. The CEOs of the company are Werner Josef Frantsits, Anton Dallos. Alvetra & Werfft was acquired by SANOCHEMIA Pharmazeutika GmbH from J. Medinger & Söhne KG on September 21, 2011 for $7.06 million. | Health Technology |
| Alvetra und Werfft Animal Nutrition GmbH | |
Waldheim Pharmazeutika GmbH
Waldheim Pharmazeutika GmbH Pharmaceuticals: MajorHealth Technology Waldheim Pharmazeutika GmbH manufactures pharmaceutical products. The private company is based in Vienna, Austria. | Health Technology |
